HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-12-09EMA Authorised: Eviplera (emtricitabine;rilpivirine hydrochloride;tenofovir disoproxil fumarate) — Gilead Sciences International Ltd
The EMA authorised Eviplera, a fixed-dose combination of emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, for HI…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Incidence of HANA Conditions in HIV-infected Individuals
This completed clinical trial evaluated the incidence of HIV-associated non-AIDS (HANA) conditions in HIV-infected individuals, and results …
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Pre-Exposure Prophylaxis in the Emergency Department [NA]
Clinical trial evaluating pre-exposure prophylaxis for HIV prevention in emergency department settings has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed
A completed clinical trial assessed using therapeutic drug monitoring to optimize antiretroviral regimens in HIV-infected women who want to …
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South [NA]
This clinical trial reports completion of a multi-component intervention aimed at training healthcare providers to promote PrEP use among gi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Mobilizing Social Network Resources for HIV Care Support [NA]
Clinical trial update describing a study to mobilize social network resources for HIV care support, sponsored by Medical College of Wisconsi…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected [Phase 1]
This update outlines a Phase 1 study evaluating the safety and immunogenicity of the 426c.Mod.Core-C4b vaccine with 3M-052-AF+Alum in infant…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Addressing the Continuum of Care Among High-risk Thai Men [NA]
Completed clinical trial addressing the continuum of care for HIV/AIDS and sexually transmitted infections among high-risk Thai men; results…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Testing a Gender-inclusive HIV Prevention Program [NA]
This clinical trial is testing a gender-inclusive HIV prevention program and is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Intervention to Improve HIV Self-care Among People Who Inject Drugs [NA]
This entry reports that a Massachusetts General Hospital-sponsored trial evaluating an intervention to improve HIV self-care among people wh…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV [NA]
This clinical trial update shows that the study is currently recruiting to evaluate whether high-intensity exercise can attenuate cognitive …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Cognitive Behavior Therapy (CBT)-Based Group Intervention to Reduce Inflammation in Older People With HIV [NA]
An update on a clinical trial testing a CBT-based group intervention to reduce inflammation in older adults with HIV, which has completed. T…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys [NA]
A clinical trial update for a text-message–based HIV prevention program aimed at men who have sex with men, sponsored by the Center for Inno…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy [Phase 3]
A Phase 3 clinical trial update evaluating an oral once-daily two-drug HIV regimen versus a three-drug regimen in adults with no prior antir…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya [NA]
This clinical trial update reports the completion of a study evaluating Problem Management Plus, a psychosocial intervention, among pregnant…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
Clinical trial update describing training for Louisiana pharmacists to implement PrEP prescribing and establish an active PrEP prescribing s…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: HIV Prevention Peer Navigation for Justice Involved Women [NA]
Clinical trial investigating HIV prevention peer navigation for justice-involved women has completed. The update confirms the study status b…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The Eswatini PRISM Study on Adolescents Living With HIV [NA]
The Eswatini PRISM Study is currently recruiting adolescents living with HIV. The study will explore HIV-related health and psychosocial str…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men [NA]
This clinical trial update describes a University of Miami–sponsored program to increase PrEP awareness and access among men who have sex wi…
-
EMA approval · 2025-12-03EMA Authorised: Delstrigo (doravirine;lamivudine;tenofovir disoproxil fumarate) — Merck Sharp & Dohme B.V.
EMA authorised Delstrigo, a fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate, for HIV infections. T…
-
EMA approval · 2025-12-02EMA Authorised: Kaletra (lopinavir;ritonavir) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Kaletra (lopinavir/ritonavir) for HIV infections, with AbbVie Deutschland GmbH & Co. KG as the mark…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers [Phase 1]
Phase 1 study evaluating the effect of dolutegravir on whole-body insulin sensitivity, lipid profile, and endocrine markers in healthy volun…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin [Phase 1]
A Phase 1 clinical trial update examining how dolutegravir behaves pharmacokinetically in HIV-infected children coinfected with tuberculosis…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People With HIV
This completed clinical trial evaluated the safety and immunogenicity of a COVID-19 vaccine in people living with HIV.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents [NA]
A completed feasibility study explores whether economic approaches can help prevent substance abuse among adolescents, including issues rela…